1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine

Metabolite details

Identifier

UIXXHROAQSBBOV-PSXMRANNSA-N

InChI Key

UIXXHROAQSBBOV-PSXMRANNSA-N

IUPAC name

(2R)-3-(hexadecanoyloxy)-2-(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl phosphate

Preferred name

1-palmitoyl-2-myristoyl-sn-glycero-3-phosphocholine

INN name

—

Synonym

1-hexadecanoyl-2-tetradecanoyl-sn-phosphatidylcholine

ChEBI

CHEBI:75304

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Novel Potential Diagnostic Serum Biomarkers of Metabolomics in Osteoarticular Tuberculosis Patients: A Preliminary Study
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Global Analyses of Selective Insulin Resistance in Hepatocytes due to Palmitate Lipotoxicity
• 4-Octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING

Observed in differential profiles

• Wild_type_vs_hfq
• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• G1_Control_vs_G2_Arginine_Addition
• Control_12h_vs_Toxocara canis_12h
• Healthy_Control_vs_Osteoarticular_Tuberculosis
• Knockdown_vs_Control
• Knockdown_vs_Control
• Control_vs_Palmitate
• Control_vs_DMXAA16h